Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-04

Clinical Trial Update: Efficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept Study [Phase 2]

View source ↗

Summary

Phase 2 proof-of-concept study evaluating the efficacy and safety of COMP360 psilocybin therapy in adults with anorexia nervosa; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • COMP360 (psilocybin)

Snippet

Sponsor: COMPASS Pathways | Conditions: Anorexia Nervosa | Phase 2 | Status: COMPLETED